Transition metal-based drugs as cancer therapeutics: an interview with Rianne Lord
At the 256th National Meeting and Exposition of the American Chemical Society (19 –23 August, 2018) we spoke with Rianne Lord, lecturer at the University of Bradford, to learn more about her work on transition metal compounds as potential drug candidates.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>